missing translation for 'onlineSavingsMsg'
Läs mer
Läs mer
Invitrogen™ ABCB9 Polyclonal Antibody

Goat Polyclonal Antibody
Brand: Invitrogen™ PA518117
Denna artikel kan inte returneras.
Se returpolicy
Beskrivning
This antibody is tested in Peptide ELISA: antibody detection limit dilution 64,000. Preliminary analysis showed no signal in Western Blot.
The structure specific ERCC 1 / XPF endonuclease complex is implicated in the repair of two distinct types of lesions in DNA: NER for UV induced lesions and bulky chemical adducts; and recombination repair of the very genotoxic interstrand cross links. NER mechanism involves dual incisions on both sides of the damage catalyzed by two nucleases. In mammalian cells, XPG cleaves 3' of the DNA lesion while the ERCC1 / XPF complex makes the 5' incision. ERCC1 / XPF probably plays a role in processing partially processed recombination intermediates.
Specifikationer
| ABCB9 | |
| Polyclonal | |
| Unconjugated | |
| ABCB9 | |
| ABC transporter 9 protein; ABCB9; ATP binding cassette subfamily B member 9; ATP-binding cassette sub-family B member 9; ATP-binding cassette transporter 9; ATP-binding cassette, subfamily B (MDR/TAP), member 9; ATP-binding cassette, sub-family B (MDR/TAP), member 9; ATP-binding cassette, sub-family B, member 9; EST122234; KIAA1520; LOW QUALITY PROTEIN: ATP-binding cassette sub-family B member 9; mABCB9; mKIAA1520; TAPL; TAP-like ABC transporter; TAP-like protein | |
| Goat | |
| Ammonium sulfate precipitation | |
| RUO | |
| 23457 | |
| -20°C, Avoid Freeze/Thaw Cycles | |
| Liquid |
| Immunohistochemistry (Paraffin) | |
| 0.5 mg/mL | |
| TBS with 0.5% BSA and 0.02% sodium azide; pH 7.3 | |
| Q9NP78 | |
| ABCB9 | |
| Synthetic peptide sequence (GHNEPVANGSHKA) corresponding to the C-terminus amino acids of ABCB9 (aa 754-766). | |
| 100 μg | |
| Primary | |
| Human | |
| Antibody | |
| IgG |
Korrigering av produktinnehåll
Din input är viktig för oss. Fyll i det här formuläret för att ge feedback relaterad till innehållet på denna produkt.
Produkttitel
Hittar du en möjlighet till förbättring?Dela en innehållskorrigering